CELLULARLINE SPA (CELL.MI) Stock Fundamental Analysis
BIT:CELL - Euronext Milan - IT0005244618 - Common Stock - Currency: EUR
We assign a fundamental rating of 6 out of 10 to CELL. CELL was compared to 29 industry peers in the Technology Hardware, Storage & Peripherals industry. CELL has an excellent financial health rating, but there are some minor concerns on its profitability. CELL may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
CELL had positive earnings in the past year.
CELL had a positive operating cash flow in the past year.
In multiple years CELL reported negative net income over the last 5 years.
Each year in the past 5 years CELL had a positive operating cash flow.
1.2 Ratios
The Return On Assets of CELL (2.73%) is better than 64.29% of its industry peers.
Looking at the Return On Equity, with a value of 4.63%, CELL is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.89%, CELL is in the better half of the industry, outperforming 60.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.73% | ||
| ROE | 4.63% | ||
| ROIC | 4.89% |
ROA(3y)-11.57%
ROA(5y)-4.81%
ROE(3y)-18.94%
ROE(5y)-8.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CELL has a Profit Margin (2.56%) which is comparable to the rest of the industry.
CELL's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 4.04%, CELL is in line with its industry, outperforming 53.57% of the companies in the same industry.
In the last couple of years the Operating Margin of CELL has declined.
Looking at the Gross Margin, with a value of 39.99%, CELL is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
In the last couple of years the Gross Margin of CELL has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.04% | ||
| PM (TTM) | 2.56% | ||
| GM | 39.99% |
OM growth 3Y65.67%
OM growth 5Y-31.71%
PM growth 3Y-44.56%
PM growth 5Y-41.99%
GM growth 3Y-3.54%
GM growth 5Y-5.29%
2. Health
2.1 Basic Checks
CELL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CELL has less shares outstanding
The number of shares outstanding for CELL has been increased compared to 5 years ago.
The debt/assets ratio for CELL has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.63 indicates that CELL is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CELL (2.63) is better than 67.86% of its industry peers.
The Debt to FCF ratio of CELL is 1.86, which is an excellent value as it means it would take CELL, only 1.86 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.86, CELL is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
CELL has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CELL (0.16) is better than 89.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.86 | ||
| Altman-Z | 2.63 |
ROIC/WACC0.58
WACC8.48%
2.3 Liquidity
A Current Ratio of 2.17 indicates that CELL has no problem at all paying its short term obligations.
CELL has a Current ratio of 2.17. This is in the better half of the industry: CELL outperforms 75.00% of its industry peers.
CELL has a Quick Ratio of 1.42. This is a normal value and indicates that CELL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.42, CELL is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.17 | ||
| Quick Ratio | 1.42 |
3. Growth
3.1 Past
CELL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 117.08%, which is quite impressive.
Measured over the past years, CELL shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -35.26% on average per year.
CELL shows a small growth in Revenue. In the last year, the Revenue has grown by 6.63%.
CELL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.08% yearly.
EPS 1Y (TTM)117.08%
EPS 3Y-36.51%
EPS 5Y-35.26%
EPS Q2Q%-35.61%
Revenue 1Y (TTM)6.63%
Revenue growth 3Y14.92%
Revenue growth 5Y11.08%
Sales Q2Q%1.99%
3.2 Future
The Earnings Per Share is expected to grow by 11.80% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.29% on average over the next years.
EPS Next Y4.17%
EPS Next 2Y11.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.91%
Revenue Next 2Y4.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 9.32 indicates a reasonable valuation of CELL.
Compared to the rest of the industry, the Price/Earnings ratio of CELL indicates a rather cheap valuation: CELL is cheaper than 85.71% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CELL to the average of the S&P500 Index (29.35), we can say CELL is valued rather cheaply.
The Price/Forward Earnings ratio is 5.33, which indicates a rather cheap valuation of CELL.
Based on the Price/Forward Earnings ratio, CELL is valued cheaper than 96.43% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CELL to the average of the S&P500 Index (22.10), we can say CELL is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.32 | ||
| Fwd PE | 5.33 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CELL is valued cheaply inside the industry as 96.43% of the companies are valued more expensively.
96.43% of the companies in the same industry are more expensive than CELL, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.05 | ||
| EV/EBITDA | 3.11 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CELL does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.24
PEG (5Y)N/A
EPS Next 2Y11.8%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.32%, CELL has a reasonable but not impressive dividend return.
CELL's Dividend Yield is rather good when compared to the industry average which is at 2.22. CELL pays more dividend than 89.29% of the companies in the same industry.
CELL's Dividend Yield is a higher than the S&P500 average which is at 2.33.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.32% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y11.8%
EPS Next 3YN/A
BIT:CELL (3/6/2025, 4:32:31 PM)
2.61
0 (0%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)
Earnings (Next)
Inst Owners8.4%
Inst Owner ChangeN/A
Ins Owners16.79%
Ins Owner ChangeN/A
Market Cap57.08M
Analysts82.86
Price Target4.79 (83.52%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.32% |
Yearly Dividend0.05
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-7.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.32 | ||
| Fwd PE | 5.33 | ||
| P/S | 0.24 | ||
| P/FCF | 3.05 | ||
| P/OCF | 2.34 | ||
| P/B | 0.43 | ||
| P/tB | 1.15 | ||
| EV/EBITDA | 3.11 |
EPS(TTM)0.28
EY10.73%
EPS(NY)0.49
Fwd EY18.76%
FCF(TTM)0.86
FCFY32.79%
OCF(TTM)1.11
OCFY42.68%
SpS10.99
BVpS6.08
TBVpS2.27
PEG (NY)2.24
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.73% | ||
| ROE | 4.63% | ||
| ROCE | 5.78% | ||
| ROIC | 4.89% | ||
| ROICexc | 5.54% | ||
| ROICexgc | 12.61% | ||
| OM | 4.04% | ||
| PM (TTM) | 2.56% | ||
| GM | 39.99% | ||
| FCFM | 7.79% |
ROA(3y)-11.57%
ROA(5y)-4.81%
ROE(3y)-18.94%
ROE(5y)-8.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y121.51%
ROICexcg growth 5Y-19.62%
ROICexc growth 3Y135.41%
ROICexc growth 5Y-15.19%
OM growth 3Y65.67%
OM growth 5Y-31.71%
PM growth 3Y-44.56%
PM growth 5Y-41.99%
GM growth 3Y-3.54%
GM growth 5Y-5.29%
F-Score7
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.86 | ||
| Debt/EBITDA | 0.91 | ||
| Cap/Depr | 41.97% | ||
| Cap/Sales | 2.35% | ||
| Interest Coverage | 2.81 | ||
| Cash Conversion | 105.12% | ||
| Profit Quality | 304.1% | ||
| Current Ratio | 2.17 | ||
| Quick Ratio | 1.42 | ||
| Altman-Z | 2.63 |
F-Score7
WACC8.48%
ROIC/WACC0.58
Cap/Depr(3y)22.68%
Cap/Depr(5y)44.4%
Cap/Sales(3y)3.65%
Cap/Sales(5y)5.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.08%
EPS 3Y-36.51%
EPS 5Y-35.26%
EPS Q2Q%-35.61%
EPS Next Y4.17%
EPS Next 2Y11.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.63%
Revenue growth 3Y14.92%
Revenue growth 5Y11.08%
Sales Q2Q%1.99%
Revenue Next Year0.91%
Revenue Next 2Y4.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y188.79%
EBIT growth 3Y90.38%
EBIT growth 5Y-24.15%
EBIT Next Year53.4%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y11796.2%
FCF growth 3Y92.9%
FCF growth 5Y-5.4%
OCF growth 1Y404.33%
OCF growth 3Y4.89%
OCF growth 5Y0.5%